Determination of N-nitrosodimethyl amine impurity in valsartan by HPLC and LC-MS/MS methods-Reference-Cited by-同舟云学术

Determination of N-nitrosodimethyl amine impurity in valsartan by HPLC and LC-MS/MS methods

Published:2022-11 Issue:11 Volume:50 Page:100150
ISSN:1872-2040
Container-title:Chinese Journal of Analytical Chemistry
language:en
Short-container-title:Chinese Journal of Analytical Chemistry

Author:

TARAWNEH Ibrahim N.^ORCID,SHMEIS Reham Abu,ALFUQAHA Shaher M.,AL OMARI Mahmoud M.

Publisher

Elsevier BV

Subject

Analytical Chemistry

Reference29 articles.

1. Impurity profiling of drugs towards safety and efficacy: theory and practice;Dhangar;J Chil Chem Soc,2017

2. Stability testing of new drug substances and products. Q1A (R2);Guideline;International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use,2003

3. Valsartan recall: global regulatory overview and future challenges;Farrukh;Ther Adv Drug Saf,2019

4. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist;Sampath;J Pharm Biomed Anal,2009

5. Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products;Masada;Sci Rep,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

2. DETERMINATION OF N-NITROSODIMETHYL AMINE (NDMA) AND N-NITROSODIETHYL AMINE (NDEA) IN MEDICINES CONTAINING SARTAN AND ITS DERIVATIVES;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-08-15

3. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry;Journal of Pharmaceutical Sciences;2023-05